University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) — Aurora, Colorado

University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) has participated in 15 clinical trials with 3 currently active.

Therapeutic areas: Gastrointestinal Tumors, Colorectal Adenocarcinomas, Gastric Adenocarcinomas.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Celcuity Inc.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)?

University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) conducted?

University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) has 15 clinical trials on record, with 3 currently active. Their work covers Gastrointestinal Tumors, Colorectal Adenocarcinomas, Gastric Adenocarcinomas.

Is University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) accredited by Crixeo Health?

University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.